GSK plc (LON:GSK)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 1,890.00
0.00 (0.00%)
Nov 6, 2026, 4:37 PM GMT
GSK plc Market Cap
GSK plc has a market cap or net worth of 75.77 billion as of November 6, 2026. It is the 220th most valuable company in the world and the 9th biggest in the United Kingdom. Its market cap has increased by 5.44% in one year.
Market Cap
75.77B
Enterprise Value
96.22B
Revenue
33.54B
Global Rank
Country Rank
#9 United Kingdom
PE Ratio
17.72
ChartMarket Cap Chart
Since April 12, 2000, GSK plc's market cap has increased from 67.16B to 75.77B, an increase of 12.82%. That is a compound annual growth rate of 0.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 75.77B | 3.51% |
| Dec 31, 2025 | 73.20B | 33.23% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.06B |
| Haleon | 29.80B |
| Smith & Nephew | 9.72B |
| Convatec Group | 4.89B |
| Hikma Pharmaceuticals | 3.45B |
| Oxford Nanopore Technologies | 2.01B |
| HUTCHMED (China) | 1.91B |
| Genus | 1.54B |